Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment
– Multiple Clinical Presentations at Kidney Week 2014 – – Studies Report Clinical Benefits of Ongoing Soliris Therapy in Children and Adults Regardless of Dialysis or Transplant History – – New aHUS Registry Data Enhance the Understanding of aHUS – CHESHIRE, Conn. November 15, 2014 –(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers presented data […]